US Stock MarketDetailed Quotes

BOW Bowhead Specialty

Watchlist
  • 31.780
  • +0.390+1.24%
Close Jan 24 16:00 ET
  • 31.780
  • 0.0000.00%
Post 16:01 ET
1.04BMarket Cap35.27P/E (TTM)

Bowhead Specialty Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bowhead Specialty Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 114.096M--
--2024/Q4-- / 102.122M--
Nov 5, 20242024/Q3116.761M / 117.071M--
Aug 6, 20242024/Q298.898M / 97.965M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 114.096M--
--2024/Q4-- / 102.122M--
Nov 5, 20242024/Q3116.761M / 117.071M--
Aug 6, 20242024/Q298.898M / 97.965M--
--------

Unlock Free Earnings Estimates

Bowhead Specialty Earnings Reports

  • Bowhead Specialty | 10-Q: Quarterly report

    Nov 5, 2024 07:21 ET

  • Bowhead Specialty | 8-K: Bowhead Specialty Holdings Inc. Reports Third Quarter 2024 Results

    Nov 5, 2024 07:16 ET

  • Bowhead Specialty | 8-K: Bowhead Specialty Holdings Inc. Announces Preliminary Third Quarter 2024 Results

    Oct 21, 2024 17:10 ET

  • Bowhead Specialty | 8-K: Bowhead Specialty Holdings Inc. Reports Second Quarter 2024 Results

    Aug 14, 2024 16:37 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Collegium Pharmaceutical
    COLL
    +2.36%
    Constellation Brands
    STZ
    +2.01%
    Ermenegildo Zegna NV
    ZGN
    +1.57%
    DexCom
    DXCM
    +1.20%
    Workday
    WDAY
    +1.17%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 24, 2025

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data